TLR4 and polycystic ovary syndrome: In conclusion, our investigation revealed that BSHZF alleviates PCOS pathogenesis by improving the gut microbiota function and inhibiting LPS/TLR4 signaling, thus providing a novel mechanistic insight into the therapeutic function of BSHZF in PCOS.